
Top news of the day from across the health care landscape.
Cefiderocol (Fetroja, Shionogi) is indicated for adults with complicated urinary tract infections, including kidney infections caused by Gram-negative pathogens, who have limited or no alternative treatment options.
Cenobamate is an investigational antiepileptic drug that has shown broad spectrum anticonvulsant activity in preclinical studies and seizure models.
Centers for Disease Control and Prevention warns the time for action is now in the "post-antibiotic era."
Receiving a flu shot before a heart bypass surgery can stop inflammation throughout the body and possibly lead to a healthier recovery, according to a preliminary study presented at the American Heart Association’s Scientific Sessions in Philadelphia, Pennsylvania.
Alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, was compared with a placebo in patients with ACS and persistent dyslipidemia, in addition to receiving treatment with high-intensity or maximum tolerated statin therapy.
Neither vitamin D nor omega-3 fatty acid supplementation were found to significantly inhibit changes in serum creatinine and cystatin C decline over 5 years among adults with type 2 diabetes.
The online resource features CBD products that have been tested for concentrations of all cannabinoids, including CBD and tetrahydrocannabinol (THC), by an independent, third-party lab, as well as experts that pharmacists can contact with questions regarding buying, selling, and marketing.
The injectable hormone tesamorelin was found to reduce liver fat and prevent liver fibrosis or scarring in people living with HIV, according to researchers and the National Institutes of Health and the National Institute of Allergy and Infectious Disease (NIAD).
A recent study published in CANCER indicates that for patients with both HIV and cancer, implementation of the Patient Protection and Affordable Care Act (ACA) improved insurance coverage, both in states that expanded Medicaid coverage and in states that did not.1
InsightRx, a company specializing in precision medicine, and Premier Inc, a health care improvement company, have partnered to individualize medication dosing for drugs used to treat infectious diseases.
Top news of the day from across the health care landscape.
Roxadustat for the treatment of patients with anemia from chronic kidney disease was shown to have positive efficacy and no increased cardiovascular risk in patients dependent and not dependent on dialysis.
What is causing a positive drug test in a patient that only takes blood pressure medications?
With expanding pharmacy practice, it is time to explore conflict management, and its necessity in this current climate.
The discovery is the first time a new subtype of HIV-1 has been identified since 2000.
Top news of the day from across the health care landscape.
Top news of the day from across the health care landscape.
In an interview with Pharmacy Times®, Claire Morton Reynolds, MBA, senior industry analyst of Nutrition Business Journal (NBJ), said that homeopathic medicine may be the industry to watch on pharmacy shelves.
Medication errors associated with OTC cough and cold products highlight an important counseling opportunity for community pharmacists that is particularly relevant as winter approaches.
Informed by the newly released NCPA 2019 Digest, members of community pharmacy organizations elaborate on the ongoing discussion of value-based care and reimbursement for community pharmacists.
For otherwise healthy patients, natural products can help alleviate flu symptoms when antivirals are not indicated.
Some fourth-year pharmacy students have brought new meaning to the phrase “back to basics,” by participating in an elective rotation at the Colonial Williamsburg apothecary.
Dicyclomine Hydrochloride Injectable is the generic version of Bentyl from Allergan and is used to treat functional bowel or irritable bowel syndrome.
Why is KS experiencing hypertension?
Omeprazole magnesium, amoxicillin, and rifabutin (Talicia, RedHill Biopharma) is indicated for the treatment of Helicobacter pylori (H. pylori) infection in adults.
Top news of the day from across the health care landscape.
Advancements in the understanding of asthma pathophysiology has led to the discovery of defined asthma phenotypes and targeted interventions involving novel biologic therapies.
Although the levels of NDMA that was found through FDA testing are much lower than the levels that a few third-party investigators claimed, the report indicated that these levels exceed what the FDA considers acceptable for these medicines.
A recent study demonstrated that budesonide-formoterol is superior to albuterol for as-needed exacerbation prevention in mild asthma.